Süleyman Serdar KOCA, Cemal ORHAN, Ahmet KARATAŞ, İbrahim Hanifi ÖZERCAN, Mehmet TUZCU, Kazim ŞAHİN, Nurhan ŞAHİN, Vijaya JUTURU

Mango ginger (curcuma amada) inhibits collagen-induced arthritis by modulating inflammatory cytokine levels in rats

Background/aim: Mango ginger (MG: curcuma amada) has antioxidant and antiinflammatory activities. The aim was to evaluate the antiarthritic potential efficacy of MG on collagen-induced arthritis. Materials and methods: Twenty-one female Wistar-albino rats were divided into three groups. Arthritis was induced by intradermal injections of type II collagen and Freund’s adjuvant. MG extract was orally administered starting from the first collagen injection. TNF-α, IL-6, IL-17, obestatin, sclerostin, and DKK-1 serum levels were determined, and perisynovial inflammation and cartilage-bone destruction in the paws were histologically evaluated. Moreover, joint tissue TNF-α, IL-17, NF-κB, and COX-2 levels were analyzed. Results: TNF-α, IL-17, IL-6, and DKK-1 serum levels were increased, and obestatin and sclerostin serum levels were decreased in the arthritis group compared to the control group. However, MG supplements decreased TNF-α, IL-17, IL-6, and DKK-1 serum levels and increased obestatin and sclerostin serum levels. Similarly, while collagen injection increased tissue TNF-α, IL-17, NF-κB, and COX2 levels, MG decreased TNF-α, IL-17, and NF-κB levels. Moreover, MG ameliorated perisynovial inflammation and cartilage-bone destruction in the paws. Conclusion: MG ameliorates arthritis via actions on inflammatory ways and wingless (Wnt) signaling pathway. These results suggest that MG may have a considerable potential efficacy for the treatment of rheumatoid arthritis.

PDF

___

1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016; 388(10055): 2023-2038. doi: 10.1016/S0140- 6736(16)30173-8
2. Angelotti F, Parma A, Cafaro G, Capecchi R, Alunno A et al. One year in review 2017: pathogenesis of rheumatoid arthritis. Clinical Experimental Rheumatology 2017; 35(3): 368-378.
3. Kotake S, Nanke Y, Mogi M, Kawamoto M, Furuya T et al. Ifn-Gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of Rankl. European Journal of Immunology 2005; 35(11): 3353-3363. doi: 10.1002/eji.200526141
4. Miao CG, Yang YY, He X, Li XF, Huang C et al. Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cellular Signalling 2013; 25(10): 2069-2078. doi: 10.1016/j. cellsig.2013.04.002
5. Niehrs C, Acebron SP. Mitotic and mitogenic Wnt signalling. The EMBO Journal 2012; 31(12): 2705-2713. doi: 10.1038/ emboj.2012.124
6. Maeda K, Takahashi N, Kobayashi Y. Roles of Wnt signals in bone resorption during physiological and pathological states. Journal of Molecular Medicine 2013; 91(1): 15-23. doi: 10.1007/s00109-012-0974-0
7. Moester MJ, Papapoulos SE, Löwik CW, van Bezooijen RL. Sclerostin: current knowledge and future perspectives. Calcified Tissue International 2010; 87(2): 99-107. doi: 10.1007/s00223-010-9372-1
8. Swierkot J, Nowak B, Czarny A, Zaczyńska E, Sokolik R et al. The activity of JAK/STAT and NF-kappaB in patients with rheumatoid arthritis. Advances in Clinical and Experimental Medicine 2016; 25(4): 709-717. doi: 10.17219/acem/61034
9. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science 2005; 310(5750): 996- 999. doi: 10.1126/science.1117255
10. Koca SS, Ozgen M, Aydin S, Dag S, Evren B et al. Ghrelin and obestatin levels in rheumatoid arthritis. Inflammation 2008; 31(5): 329-335. doi: 10.1007/s10753-008-9082-2
11. Mujumdar AM, Naik DG, Misar AV, Puntambekar HM, Dandge CN. CNS depressant and analgesic activity of a fraction isolated from ethanol extract of Curcuma amada rhizomes. Pharmaceutical Biology 2004; 42(7): 542-546. doi: 10.3109/13880200490893429
12. Sahin K, Orhan C, Tuzcu M, Sahin N, Erten F, Juturu V. Capsaicinoids improve consequences of physical activity. Toxicology Reports 2018; 5: 598-607. doi: 10.1016/j. toxrep.2018.05.001
13. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. The Journal of Experimental Medicine 1977; 146(3): 857-868. doi: 10.1084/ jem.146.3.857
14. Ramachandran C, Portalatin GM, Prado AM, Quirin KW, Escalon E et al. In vivo antitumor effect of supercritical CO(2) Extract of mango ginger (curcuma amada roxb) in U-87MG human glioblastoma nude mice xenografts. Journal of Evidence-Based Complementary and Alternative Medicine 2017; 22(2): 260-267. doi: 10.1177/2156587216659390
15. Larsson P, Kleinau S, Holmdahl R, Klareskog L. Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis and Rheumatism 1990; 33(5): 693-701. doi: 10.1002/art.1780330512
16. Choi J, Yoon BJ, Han YN, Lee KT, Ha J et al. Antirheumatoid arthritis effect of Rhus verniciflua and of the active component, sulfuretin. Planta Medica 2003; 69(10): 899-904. doi: 10.1055/ s-2003-45097
17. Nestoriuc Y, Orav EJ, Liang MH, Horne R, Barsky AJ. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care Research (Hoboken) 2010; 62(6): 791-799. doi: 10.1002/acr.20160
18. Policegoudra RS, Aradhya SM, Singh L. Mango ginger (Curcuma amada Roxb.)--a promising spice for phytochemicals and biological activities. Journal of Biosciences 2011; 36(4): 739-748. doi: 10.1007/s12038-011-9106-1
19. Ahmadi M, Rasekh HR, Kamali-Nejad M, Zare A. Antiinflammatory effects of total extract of curcuma amada roxb. in a rheumatoid arthritis rat model. Journal of Medicinal Plants 2008; 1(25): 21-28.
20. Mujumdar AM, Naik DG, Dandge CN, Puntambekar HM. Anti-inflammatory activity of curcuma amada Roxb. in albino rats. Indian Journal Pharmacology 2000; 32: 375-377.
21. Kotake S, Yago T, Kobashigawa T, Nanke Y. The Plasticity of Th17 cells in the pathogenesis of rheumatoid arthritis. Journal of Clinical Medicine 2017; 6(7): E67. doi: 10.3390/jcm6070067
22. Fox DA. Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor. Archives of Internal Medicine 2000; 160(4): 437-444. doi: 10.1001/archinte.160.4.437
23. Camussi G, Lupia E. The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis. Drugs 1998; 55(5): 613-620. doi: 10.2165/00003495- 199855050-00001
24. Matsuno H, Sawai T, Nezuka T, Uzuki M, Tsuji H et al. Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model. Arthritis and Rheumatism 1998; 41(11): 2014- 2021. doi: 10.1002/1529-0131(199811)41:11<2014::AIDART17>3.0.CO;2-T
25. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS et al. Dickkopf-1 is a master regulator of joint remodeling. Nature Medicine 2007; 13(2): 156-163. doi: 10.1038/nm1538
26. Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Developmental Cell 2005; 8(5): 751- 764. doi: 10.1016/j.devcel.2005.02.017
27. Caetano-Lopes J, Rodrigues A, Lopes A, Vale AC, Pitts-Kiefer MA et al. Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression. Clinical Reviews in Allergy and Immunology 2014; 47(1): 38-45. doi: 10.1007/s12016-013-8366-y
28. Yeremenko N, Zwerina K, Rigter G, Pots D, Fonseca JE et al. Tumor necrosis factor and interleukin-6 differentially regulate Dkk-1 in the inflamed arthritic joint. Arthritis and Rheumatology 2015; 67(8): 2071-2075. doi: 10.1002/art.39183
29. Braun T, Zwerina J. Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Research and Therapy 2011; 13(4): 235. doi: 10.1186/ar3380
30. Chen XX, Baum W, Dwyer D, Stock M, Schwabe K et al. Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis. Annals of The Rheumatic Diseases 2013; 72(10): 1732-1736. doi: 10.1136/annrheumdis-2013-203345
31. Paccou J, Mentaverri R, Renard C, Liabeuf S, Fardellone P et al. The relationships between serum sclerostin, bone mineral density, and vascular calcification in rheumatoid arthritis. The Journal of Clinical Endocrinology and Metabolism 2014; 99(12): 4740-4748. doi: 10.1210/jc.2014-2327
32. Mehaney DA, Eissa M, Anwar S, Fakhr El-Din S. Serum sclerostin level among egyptian rheumatoid arthritis patients: relation to disease activity, bone mineral density and radiological grading. Acta Reumatológica Portuguesa 2015; 40(3): 268-274
33. Wehmeyer C, Frank S, Beckmann D, Böttcher M, Cromme C et al. Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction. Science Translational Medicine 2016; 8(330): 330ra35. doi: 10.1126/scitranslmed. aac4351
34. Aupperle K, Bennett B, Han Z, Manning A, Firestein G. NFkappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes. The Journal of Immunology. 2001; 166(4): 2705-2711. doi: 10.4049/jimmunol.166.4.2705
35. Wu MY, Yang RS, Lin TH, Tang CH, Chiu YC et al. Enhancement of PLGF production by 15-(S)-HETE via PI3KAkt, NF-κB and COX-2 pathways in rheumatoid arthritis synovial fibroblast. European Journal of Pharmacology 2013; 714(1-3): 388-396. doi: 10.1016/j.ejphar.2013.07.010
36. Bremner P, Heinrich M. Natural products as targeted modulators of the nuclear factor-kappaB pathway. The Journal of Pharmacy and Pharmacology 2002; 54(4): 453-472. doi: 10.1211/0022357021778637
37. Taylor BS, de Vera ME, Ganster RW, Wang Q, Shapiro RA et al. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. The Journal of Biological Chemistry 1998; 273(24): 15148- 15156. doi: 10.1074/jbc.273.24.15148
38. Dembiński A, Warzecha Z, Ceranowicz P, Cieszkowski J, Dembiński M et al. Administration of obestatin accelerates the healing of chronic gastric ulcers in rats. Medical Science Monitor 2011; 17(8): BR196-200. doi: 10.12659/msm.881897
39. Şen LS, Karakoyun B, Yeğen C, Akkiprik M, Yüksel M et al. Treatment with either obestatin or ghrelin attenuates mesenteric ischemia-reperfusion-induced oxidative injury of the ileum and the remote organ lung. Peptides 2015; 71: 8-19. doi: 10.1016/j.peptides.2015.04.014
40. Kellokoski E, Kunnari A, Jokela M, Mäkelä S, Kesäniemi YA et al. Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding. Metabolism 2009; 58(11): 1572-15780. doi: 10.1016/j.metabol.2009.05.009
41. Alexandridis E, Zisimopoulos A, Liratzopoulos N, Katsos I, Manolas K et al. Obestatin/ghrelin ratio: a new activity index in inflammatory bowel diseases. Inflammatory Bowel Diseases 2009; 15(10): 1557-1561. doi: 10.1002/ibd.20940